Team:Paris/September 2
From 2008.igem.org
(Difference between revisions)
(→Ligation L173 (rbs-TetR in mRFP-LVA-tripart-pSB1A3)) |
(→Ligation L173 (rbs-TetR in mRFP-LVA-tripart-pSB1A3)) |
||
Line 26: | Line 26: | ||
{|border="1" style="text-align: center" | {|border="1" style="text-align: center" | ||
|rowspan="2"| | |rowspan="2"| | ||
+ | |||
|rowspan="2"|'''Control''' | |rowspan="2"|'''Control''' | ||
|colspan="2"|'''Sample''' | |colspan="2"|'''Sample''' | ||
Line 56: | Line 57: | ||
|13,1 µL | |13,1 µL | ||
|12,6 µL | |12,6 µL | ||
+ | |- | ||
+ | =Ligation L172 ('''rbs-FlhDC''' in '''mRFP-LVA-tripart'''-pSB1A3)= | ||
+ | |||
+ | |||
+ | '''Samples used''' | ||
+ | {|border="1" style="text-align: center" | ||
+ | |'''Name''' | ||
+ | |'''Digestion number''' | ||
+ | |'''Digested by''' | ||
+ | |'''DNA concentration''' | ||
+ | |- | ||
+ | |rbs-FlhDC | ||
+ | |D186 | ||
+ | |EcoRI & SpeI (insert) | ||
+ | |~24 µg/mL | ||
+ | |- | ||
+ | |mRFP-LVA-tripart | ||
+ | |D187 | ||
+ | |EcoRI & XbaI (vector) | ||
+ | |16 µg/mL | ||
|- | |- | ||
|} | |} | ||
+ | <br> | ||
+ | '''Reaction mixtures''' | ||
+ | {|border="1" style="text-align: center" | ||
+ | |rowspan="2"| | ||
+ | |rowspan="2"|'''Control''' | ||
+ | |colspan="2"|'''Sample''' | ||
+ | |- | ||
+ | |'''3:1''' (insert:vector) '''ratio''' | ||
+ | |- | ||
+ | |'''D186''' (insert) | ||
+ | |0 µL | ||
+ | |1 µL | ||
+ | |- | ||
+ | |'''D187''' (vector) | ||
+ | |2,5 µL | ||
+ | |2,5 µL | ||
+ | |} | ||
*Put in the room "Danger azote" at about 16°C at 18h00 (for overnight reaction). | *Put in the room "Danger azote" at about 16°C at 18h00 (for overnight reaction). |
Revision as of 16:46, 2 September 2008
Ligation L173 (rbs-TetR in mRFP-LVA-tripart-pSB1A3)Samples used
|